Skip to search formSkip to main contentSkip to account menu

MANGAFODIPIR

Known as: Mn-DPDP, manganese dipyridoxyl diphosphate, manganese-DPDP 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
To develop and validate an objective technique for 3D segmentation of manganese‐enhanced MR images of the optic nerve/tract (ON… 
2005
2005
Rationale and Objectives:To investigate the capacity of manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance… 
2005
2005
Rationale and Objectives:To compare manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging (MRI) with… 
2004
2004
PURPOSE To assess the accuracy of magnetic resonance (MR) with Mangafodipir (Mn-DPDP) in the identification of focal solid… 
Highly Cited
2000
Highly Cited
2000
PURPOSE To assess whether normal myocardium can be distinguished from infarction at magnetic resonance (MR) imaging with low… 
1998
1998
This spectroscopic study compares the mechanisms of the hepatic uptake of manganese chloride (MnCl2) and manganese dipyridoxyl… 
1997
1997
The purpose of the study was to evaluate the MR contrast agents gadolinium benzyloxypropionictetro‐acetate (Gd‐BOPTA) and… 
1997
1997
Our goal was to assess the utility of manganese dipyridoxyl diphosphate (MnDPDP) as a negative hepatic contrast agent in short… 
1995
1995
RATIONALE AND OBJECTIVES.Manganese dipyridoxyl diphosphate (MnDPDP) is a promising contrast agent for magnetic resonance imaging…